Dr. Aleppo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Galter 14100
Chicago, IL 60611Phone+1 312-695-7970Fax+1 312-695-4433
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2002
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1996 - 2000
- Univ Catania- Fac MedClass of 1990
Certifications & Licensure
- IL State Medical License 1996 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACE) American Association of Clinical Endocrinology
- Fellow (FACP) American College of Physicians ACP, 2012
- Join now to see all
Clinical Trials
- Study of Glycemic Control on Liver Transplantation Outcomes Start of enrollment: 2009 Apr 01
- Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes Start of enrollment: 2022 Aug 31
Roles: Contact, Principal Investigator
- Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes Start of enrollment: 2024 Mar 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 370 citationsGlucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose MonitoringRichard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks
Diabetes Care. 2018-11-01 - 126 citationsMulticenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy
Diabetes Care. 2021-06-07 - 199 citationsEffect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.Thomas W. Martens, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun
JAMA. 2021-06-08
Lectures
- Diabetes and Technology: Is Big Brother Watching?ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
- Remote Monitoring of Insulin Pump Therapy: Challenges and SuccessesENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
- Comparison of Glycemic and Surgical Outcomes in Cardiac Surgery Patients After Change in Glycemic TargetsChicago, IL - 6/14/2014
- Join now to see all
Press Mentions
- New Clinical Practice Guideline Offers Recommendations to Manage Hypoglycemia in People with DiabetesDecember 7th, 2022
- Insulin Advancements and Technology Developments from ADA 2022June 13th, 2022
- Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes at 12 Months of Use in Children 2 to 5.9 Years of AgeJune 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Fellow
Other Languages
- Spanish, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: